Aigen Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,987
| Closed | -$307K | – | 529 |
|
|
2021
Q2 | $307K | Sell |
6,987
-1,299
| -16% | -$57.1K | 0.05% | 328 |
|
|
2021
Q1 | $409K | Sell |
8,286
-4,568
| -36% | -$225K | 0.05% | 339 |
|
|
2020
Q4 | $541K | Buy |
12,854
+2,522
| +24% | +$106K | 0.07% | 369 |
|
|
2020
Q3 | $473K | Sell |
10,332
-279
| -3% | -$12.8K | 0.06% | 409 |
|
|
2020
Q2 | $533K | Sell |
10,611
-13,821
| -57% | -$694K | 0.07% | 434 |
|
|
2020
Q1 | $1.26M | Buy |
24,432
+20,217
| +480% | +$1.04M | 0.17% | 163 |
|
|
2019
Q4 | $260K | Buy |
+4,215
| New | +$260K | 0.04% | 479 |
|